Starting HAART: When to Take the First Step?
July 20, 2010
For more information on this session, including access to speaker presentations, please see the conference Programme-at-a-Glance.
Recent guidelines are all recommending that HIV treatment be started at a higher CD4 count because of issues such as the ongoing damage caused by HIV itself, and prevention of transmission. Issues in long-term treatment, such as potential side effects, the development of resistance, the cost and sustainability of programmes in resource-poor settings, are some of the potential problems for such a strategy. This session will debate, in a courtroom type setting, the pros and cons of early initiation and will highlight the areas of controversy and agreement. It will be an opportunity for patient groups and community to debate with clinicians and scientists the need to start early.
Presentations in This Session:
Scientific Perspective From a Developed Country
Scientific Perspective From a Developing Country
Questions and Answers
This article was provided by Henry J. Kaiser Family Foundation. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)